Molecular evolution of omicron variant in immunocompromised individuals with chronic SARS-CoV-2 infection - 23/11/23
Doi : 10.1016/j.jinf.2023.09.011
Camille Vellas ⁎, 1 
INSERM UMR1291-CNRS UMR5051-Université Toulouse III (University of Toulouse III), Toulouse Institute for Infectious and Inflammatory Diseases, F-31300, France
Université Toulouse III Paul Sabatier, F-31300, France
⁎Correspondence to: Toulouse Institute for Infectious and Inflammatory Diseases (INFINITY), 330 av de Grande Bretagne, 31052 Toulouse, France.Toulouse Institute for Infectious and Inflammatory Diseases (INFINITY)330 av de Grande BretagneToulouse31052France
Justine Latour, Pauline Trémeaux, Noémie Ranger, Vénicia Ferrer, Agnès Harter, Romain Carcenac, Pauline Boyer, Sofia Demmou
CHU de Toulouse (Toulouse University Hospital), Laboratoire de Virologie (Virology Laboratory), Toulouse F-31300, France
Pauline Claraz
Institut Universitaire du Cancer (University Cancer Institute), Service de Pharmacie (Pharmacy Department), Toulouse F-31100, France
Nassim Kamar
INSERM UMR1291-CNRS UMR5051-Université Toulouse III (University of Toulouse III), Toulouse Institute for Infectious and Inflammatory Diseases, F-31300, France
Université Toulouse III Paul Sabatier, F-31300, France
CHU de Toulouse, Département de Néphrologie, Dialyse et Transplantation d′Organes (Department of Nephrology, Dialysis and Organ Transplantation), Toulouse F-31400, France
Jacques Izopet
INSERM UMR1291-CNRS UMR5051-Université Toulouse III (University of Toulouse III), Toulouse Institute for Infectious and Inflammatory Diseases, F-31300, France
Université Toulouse III Paul Sabatier, F-31300, France
CHU de Toulouse (Toulouse University Hospital), Laboratoire de Virologie (Virology Laboratory), Toulouse F-31300, France
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | Immunocompromised patients are at high risk of chronic SARS-CoV-2 infection. |
• | Chronic COVID-19 in immunocompromised patients can lead to new variants. |
• | Apparition of new spike mutation is related to viral rebound. |
• | Virological monitoring of patients with chronic SARS-CoV-2 infection is necessary. |
Plan
© 2023
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 87 - N° 6
P. e89-e93 - décembre 2023 Retour au numéro
Article précédent
- Clinical metagenomics in a resource-limited setting
- Gert Marais, Ziyaad Valley-Omar, Suzaan Marais, Kate McMullen, Kathleen Bateman, Diederick van der Westhuizen, Moepeng Maseko, Diana Hardie, Adrian Brink
- Genetic characterization of a novel H5N6 subtype highly pathogenic avian influenza virus from goose in China
- Xi-Ming Lu, Xiang-Yan Feng, Yue Wu, Cheng-Bo Wen, Hao Liu, De-Xian Zhang
Bienvenue sur EM-consulte, la référence des professionnels de santé.